155 related articles for article (PubMed ID: 12356420)
1. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.
Parrott N; Lavé T
Eur J Pharm Sci; 2002 Oct; 17(1-2):51-61. PubMed ID: 12356420
[TBL] [Abstract][Full Text] [Related]
2. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Sjögren E; Thörn H; Tannergren C
Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
[TBL] [Abstract][Full Text] [Related]
3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
4. Approaches to Account for Colon Absorption in Physiologically Based Biopharmaceutics Modeling of Extended-Release Drug Products.
Jadhav H; Augustijns P; Tannergren C
Mol Pharm; 2023 Dec; 20(12):6272-6288. PubMed ID: 37902586
[TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.
Eckernäs E; Tannergren C
Mol Pharm; 2021 Apr; 18(4):1699-1710. PubMed ID: 33720733
[TBL] [Abstract][Full Text] [Related]
6. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.
Heikkinen AT; Baneyx G; Caruso A; Parrott N
Eur J Pharm Sci; 2012 Sep; 47(2):375-86. PubMed ID: 22759901
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based biopharmaceutics modeling of regional and colon absorption in humans.
Tannergren C; Jadhav H; Eckernäs E; Fagerberg J; Augustijns P; Sjögren E
Eur J Pharm Biopharm; 2023 May; 186():144-159. PubMed ID: 37028605
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.
Gobeau N; Stringer R; De Buck S; Tuntland T; Faller B
Pharm Res; 2016 Sep; 33(9):2126-39. PubMed ID: 27278908
[TBL] [Abstract][Full Text] [Related]
10. Theoretical predictions of drug absorption in drug discovery and development.
Stenberg P; Bergström CA; Luthman K; Artursson P
Clin Pharmacokinet; 2002; 41(11):877-99. PubMed ID: 12190333
[TBL] [Abstract][Full Text] [Related]
11. A physiological model for the estimation of the fraction dose absorbed in humans.
Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
[TBL] [Abstract][Full Text] [Related]
12. From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.
Willmann S; Lippert J; Schmitt W
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):159-68. PubMed ID: 16922658
[TBL] [Abstract][Full Text] [Related]
13. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption.
Shah P; Jogani V; Bagchi T; Misra A
Biotechnol Prog; 2006; 22(1):186-98. PubMed ID: 16454510
[TBL] [Abstract][Full Text] [Related]
14. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
15. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
[TBL] [Abstract][Full Text] [Related]
16. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
17. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
18. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.
Tubic-Grozdanis M; Bolger MB; Langguth P
AAPS J; 2008; 10(1):213-26. PubMed ID: 18446522
[TBL] [Abstract][Full Text] [Related]
19. Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption.
Zmuidinavicius D; Didziapetris R; Japertas P; Avdeef A; Petrauskas A
J Pharm Sci; 2003 Mar; 92(3):621-33. PubMed ID: 12587124
[TBL] [Abstract][Full Text] [Related]
20. Caco-2 cells as a model for intestinal absorption.
Angelis ID; Turco L
Curr Protoc Toxicol; 2011 Feb; Chapter 20():Unit20.6. PubMed ID: 21400683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
